Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Webcast, Advisory

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference


Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 at 8:00am Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Xeris' Investor Relations website at www.xerispharma.com. A replay of the webcast will be available for 30 days.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products: Recorlev®, for the treatment of endogenous Cushing's syndrome; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs to bring new products forward using its proprietary formulation technology platforms, XeriSol® and XeriJect®, supporting long-term product development and commercial success.

Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.


These press releases may also interest you

at 08:17
Leveling the Playing Field: Advocating for Women in Science & Research
Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the U.S. research workforce. Making up 30% of the research workforce, women continue to face systemic challenges, including gender bias, lack of...

22 mar 2025
Certain Habibi's Mediterranean brand dips recalled due to undeclared peanut
Product: Dips Issue: Food - Allergen ? Peanut Distribution:     AlbertaBritish ColumbiaPossibly other provinces and territories See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

22 mar 2025
Nature Cell's JointStem Becomes the First Korean Company to Acquire Breakthrough Therapy Designation from the U.S. FDA
-The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing treatments-The BTD designation, achieved following...

22 mar 2025
Canadian Dental Care Plan expands to include millions of new eligible Canadians
Investing in Canadians' health is key to building a stronger Canada. In its first year, the Canadian Dental Care Plan (CDCP) has significantly improved access to affordable dental care. More than 3.4 million Canadians were approved to be part of the...

22 mar 2025
Eatlove brand Organic Almond Butter Cup recalled due to undeclared peanut
Product: Organic Almond Butter Cup Issue: Food - Allergen ? Peanut Distribution:  National                      Online See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

22 mar 2025
Prime Biome Alerts Consumers About Misleading Third-Party Resellers and Reinforces Commitment to Product Integrity
The official brand behind Prime Biome has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of Prime Biome across various platforms...

More news about Health...


News published on and distributed by: